Cough Assist Devices Market Size
Hey there! Cough Assist Devices are getting more and more popular, with the market worth around $205.1 million in 2022 and expected to keep growing by over 7.2% each year until 2032. Here's whyPeople want to be cared for at home more, which means a device like this is handy. They're getting better at using technology, which makes these devices easier to use. And with more people having breathing problems, these devices are becoming more necessary. Another big factor is that we're all getting older, and older people are more likely to have trouble breathing and weak muscles. Cough assist devices are easy to use and help people clear their airways, so they're becoming more popular with older adults.

Further, cough assist devices provide a means for individuals to receive respiratory therapy at home, improving their quality of life and reducing healthcare costs associated with hospital visits. The convenience and comfort offered by home-based cough assist devices are driving market growth. Thus, such aforementioned factors are set to cumulatively drive the cough assist devices market growth in the foreseeable future.
A cough assist device, also known as a mechanical insufflator-exsufflator, is a medical device used to assist individuals with impaired cough function in clearing their airways and managing respiratory secretions. It is primarily used for people with conditions that affect the muscles involved in coughing, such as neuromuscular disorders, spinal cord injuries, or certain respiratory conditions.
Cough Assist Devices Market Report Attributes
Report Attribute |
Details |
Base Year | 2022 |
---|
Cough Assist Devices Market Size in 2022 | USD 205.1 Million |
---|
Forecast Period | 2023 to 2032 |
---|
Forecast Period 2023 to 2032 CAGR | 7.2% |
---|
2032 Value Projection | USD 419.7 Million |
---|
Historical Data for | 2018 to 2022 |
---|
No. of Pages | 180 |
---|
Tables, Charts & Figures | 359 |
Segments covered | Product Type, Choice of Delivery, End-use and Region |
---|
Growth Drivers | - Rise in prevalence of respiratory diseases
- Increasing incidences of spinal cord injuries
- Technological advancements in devices
|
---|
Pitfalls & Challenges | - High device cost
- Lack of awareness and accessibility
|
---|
Cough assist devices can be expensive, especially for individuals without insurance coverage or in regions with limited healthcare resources. The high cost of these devices can act as a barrier to adoption, limiting market growth, particularly in low-income or developing regions. Further, lack of awareness, proper training and education for patients and caregivers on the correct use of the devices can hinder their effectiveness and limit market growth. Additionally, maintenance and servicing of the devices in home settings may pose logistical challenges, potentially impacting their utilization.
COVID-19 Impact
The pandemic brought disruptions to the usual flow of goods, including medical equipment like cough assist machines. Countries had trouble trading, transporting, and finding the parts needed to make and ship these devices. This created delays and shortages. On the other hand, COVID-19 made more people sick with breathing problems. This meant that hospitals had more patients who needed help clearing mucus from their lungs. Despite the challenges, the pandemic also gave rise to new ideas and ways to give care from afar. With fewer people getting sick and new products coming out to treat and help more people, the market for cough assist devices is expected to grow quickly in the future.
Cough Assist Devices Market Trends
Respiratory illnesses are becoming more common, and this has led to a growing need for devices that help with coughing. This is especially true for people with chronic conditions like COPD and neuromuscular diseases, whose weak respiratory muscles make it hard for them to cough effectively. COPD is a serious lung disease that makes it hard to breathe. It's estimated that around 3.23 million people died from COPD in 2019, making it the third-leading cause of death worldwide. As more and more people are diagnosed with COPD, the demand for cough assist devices is expected to keep growing. Neuromuscular diseases like muscular dystrophy, spinal muscular atrophy, and ALS can also weaken respiratory muscles and make coughing difficult. These conditions are relatively rare, but they can have a devastating impact on people's lives. Cough assist devices can help improve their quality of life by making it easier for them to breathe and clear their airways.
Cough Assist Devices Market Analysis
The two main types of cough assist devices are automatic and manual. Automatic devices dominate the market, making up a large chunk of revenue. They're popular for several reasonsThey're more effective at clearing mucus and helping people cough. They can monitor and record data, making it easier for healthcare providers to track your progress. They're convenient for use at home. They're easy to operate, even for those with limited mobility. Automatic cough assist devices come with adjustable pressure settings and timing options. This means healthcare professionals can customize the device to best suit your needs. With all these advantages, the market for automatic cough assist devices is expected to thrive in the years to come.
Choosing the right delivery system for your cough assist device is important, and there are three main optionsface mask, mouthpiece, and adapter. The mouthpiece option was the most popular in 2022, and it's expected to keep growing in the coming years, potentially reaching over $190 million in sales by 2032. Mouthpiece cough assist devices are easy to use. They have a mouthpiece that you can hold in your mouth and breathe through during therapy. This is more convenient than other options because it doesn't require a mask or additional equipment. It's also more comfortable, portable, and hygienic. All of these advantages should help make mouthpiece cough assist devices even more popular in the future.

Based on end-use, the cough assist devices market is segmented into hospitals, home care settings, and others. The home care settings segment held a significant revenue share in 2022 and is anticipated to witness fastest growth to reach over USD 161.4 million in 2032. Preference for personalized care, improved quality of life, reduced risk of infections and cost-effectiveness are the key attributes propelling the homecare segmental growth. Homecare cough assist devices can be a cost-effective alternative to hospital-based care as they allow individuals to receive respiratory care in the comfort and familiarity of their own homes.
Additionally, homecare cough assist devices may eliminate the need for caregiver assistance, reducing caregiving costs. Furthermore, hospital settings can be potential sources of infections, including healthcare-associated respiratory infections. By using cough assist devices at home, individuals can minimize their exposure to pathogens and reduce the risk of acquiring infections.

Get ready, because the market for cough assist devices in the US is set to take a big leap and reach an impressive $134.5 million by 2032! This surge is fueled by a few key factorsHome is where the heart isPeople are increasingly choosing to get their healthcare at home, and cough assist devices are no exception. Tech is the future Advancements in technology have made cough assist devices more effective and easier to use. Breathing is essentialRespiratory conditions are on the rise in the US, and these devices can help people breathe better. Insurance helps Insurance companies are recognizing the importance of cough assist devices and are providing coverage for them. Age is just a number As our population ages, they're more likely to develop respiratory issues and need cough assist devices. So, there you have it! These factors are expected to give the cough assist devices market in the US a major boost in the coming years.
Cough Assist Devices Market Share
Few of the leading players operating in the cough assist devices market include
- Air Liquide Medical Systems
- United Hayek Industries Inc.
- Hill-Rom Holdings, Inc.
- Koninklijke Philips N.V.
- McKesson Medical-Surgical
- Dima Italia Srl
- Breas Medical Ltd
. The key market players are involved in developments including collaboration, mergers, product launches, and acquisition, to further strengthen their revenue generating prospectus.
Cough Assist Devices Industry News
- In November 2022, ABM Respiratory Care received a CE mark for its BiWaze Cough system. The system works with high frequency oscillation to combine assisted cough and lung expansion to remove mucus. This product launch will help the company to enhance their product portfolio and improve their business revenue.
- In July 2020, Hillrom Holdings, Inc. has launched the Synclara Cough System, a cough assist therapy. It is a noninvasive therapy to remove secretions in patients. This product launch is expected to aid the company to enhance their R&D capabilities and gain a technological advancement over its peers.
Cough assist devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million) and volume (Units) from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By Product Type
- Automatic Cough Assist Device
- Manual Cough Assist Device
By Choice of Delivery
- Face Mask
- Mouthpiece
- Adapter
By End-use
- Hospitals
- Home Care Settings
- Others
The above information is provided for the following regions and countries
- North America
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Poland
- Sweden
- The Netherlands
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Indonesia
- Philippines
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Columbia
- Peru
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Israel
- Iran